Liver transplantation for hepatic metastatic pancreatic insulinoma with a survival over five years.
- Author:
Xiao-Bo CHEN
1
;
Jie YANG
;
Ming-Qing XU
;
Lü-Nan YAN
Author Information
1. Department of Liver and Vascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Publication Type:Case Reports
- MeSH:
Humans;
Insulinoma;
secondary;
therapy;
Liver Neoplasms;
complications;
Liver Transplantation;
Male;
Middle Aged;
Pancreatic Neoplasms;
secondary;
therapy
- From:
Chinese Medical Journal
2012;125(15):2768-2771
- CountryChina
- Language:English
-
Abstract:
Pancreatic neuroendocrine tumors (NETs) are one subgroup of gastroenteropancreatic NETs. Its main characteristics are slow growth, frequent metastasis to the liver, and limited to the liver for long periods. In patients with irresectable liver metastatic NET, liver transplantation is the only radical treatment. About 160 cases of liver transplantation for liver metastatic NET have been reported worldwide. However, there is no such report of liver transplantation for hepatic metastatic NET in China by now. We herein report a case of liver transplantation for hepatic metastatic pancreatic insulinoma with a survival of over 5 years.
